Today: 11 June 2026
Browse Category

NASDAQ:BTBD 13 January 2026

Crypto ATM crackdowns are spreading — and Bitcoin Depot stock is in the frame

Crypto ATM crackdowns are spreading — and Bitcoin Depot stock is in the frame

Bitcoin Depot shares rose 4.6% to $1.37 despite mounting regulatory crackdowns on crypto ATMs following a surge in fraud. The FBI reported bitcoin ATM scam losses hit $333 million in 2025 through November, up from $250 million in 2024. Maine reached a $1.9 million settlement with Bitcoin Depot to compensate scam victims. Vermont and several cities have imposed new limits, bans, or licensing requirements on kiosks.
13 January 2026
····

Stock Market Today

  • Jobless Claims Hit 4½-Month High Despite Stable Layoffs
    June 11, 2026, 11:14 AM EDT. Jobless claims in the U.S. rose to a 4½-month high in early June, signaling more individuals accessing unemployment benefits. However, this increase does not reflect a surge in layoffs, suggesting businesses are not cutting more jobs even as claims tick up. The data indicates a complex labor market where claims may rise for reasons other than widespread job losses.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Go toTop